Environment
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
StateWashingtonIntroduced
SB 6228: Removing a tax exemption for the warehousing and reselling of prescription drugs. (REVISED FOR ENGROSSED: Removing a tax exemption for the warehousing and reselling of prescription drugs and providing tax relief for critical access pharmacies.)
Noel Frame
SB 6228 status: Introduced — Effective date 1/1/2027 (updated Apr 1, 2026).
Source
OpenStates
Confidence
Low
Analysis basis
OpenStates summary
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
65OUT OF 100
Score:65/100 civic fit
Risk:Moderate Risk
Impact:Moderate Impact 45/100
Constitutionality90%
Bipartisan50%
Public opinion60%
Bill summary
What changes
The bill eliminates a tax exemption for pharmaceutical warehousing and reselling entities and implements a new tax relief measure for small, critical access pharmacies.
Who is affected
Pharmaceutical wholesalers, distributors, and independent or essential small-scale pharmacies.
Requirements and enforcement
Wholesalers must pay tax on services previously exempted; eligible pharmacies must verify status to receive relief.
Costs and funding
Increased tax liability for wholesale and resale businesses.
When it takes effect
The provisions are set to become effective on January 1, 2027.
Potential benefits
Supports the financial sustainability of essential and rural pharmacies, protecting patient access to medication.
Risks and tradeoffs
Potential for increased operating costs in the supply chain leading to higher retail prices.
What is still unknown
The specific eligibility criteria for 'critical access' status and the total fiscal impact of the tax shift.
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Positive outlook
60%
Benefits
- Increases state tax revenue
- Provides targeted tax relief for small businesses
- Supports independent pharmacy financial viability
Risks
- Increases compliance costs for pharmaceutical wholesalers
- Potential for cost pass-through to pharmacy retail buyers
- Risk of market consolidation among distributors
Society
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Technology Industry
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Civic Accountability
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Public Health & Safety
Positive outlook
70%
Benefits
- Protects essential local pharmacy access
- Supports rural healthcare infrastructure
- Prevents closures of critical community health sites
Risks
- Risk of increased medication costs for providers
- Potential supply chain volatility during transition
- Uncertainty in patient-level pricing effects
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
OpenStates
Official bill text or data from OpenStates.
Confidence
Low
Information is limited or incomplete.
Analysis basis
OpenStates summary
Source used for this bill's analysis.
Source note
LegiScan returned a PDF-only document. PDF extraction is not enabled in this build, so the pipeline used a safer fallback.
Analysis scope
Analysis based on bill summary; full text not provided.
04
Where it stands
Official record- IntroducedCurrent
- CommitteeUpcoming
- Chamber votesUpcoming
- Final agreementUpcoming
- GovernorUpcoming
- EnactedUpcoming
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.